|
End-of-day quote
Bulgaria S.E.
29/10/2026
|
5-day change | 1st Jan Change | ||
| 3.320 EUR | +1.22% |
|
+3.75% | +133.05% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.32B 2B 1.79B 1.65B 1.49B 2.79B 190B 2.84B 19.67B 7.85B 99.46B 7.49B 7.33B 315B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.86B 2.32B 2.08B 1.92B 1.74B 3.25B 221B 3.3B 22.88B 9.13B 116B 8.71B 8.52B 366B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +1.22% | ||
| 1 week | +3.75% | ||
| Current month | +28.19% | ||
| 1 month | +30.71% | ||
| 3 months | +72.92% | ||
| 6 months | +95.29% | ||
| Current year | +133.05% |
| 1 week | 3.21 |  | 3.34 |
| 1 month | 2.49 | | 3.37 |
| Current year | 1.41 | | 3.37 |
| 1 year | 1.34 | | 3.37 |
| 3 years | 0.94 | | 3.37 |
| 5 years | 0.68 | | 3.37 |
| 10 years | 0.41 | | 3.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 30/09/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 31/12/2001 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 18/05/2010 |
| Director/Board Member | 63 | 18/05/2010 | |
| Director/Board Member | 61 | 11/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/09/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.22% | +3.75% | +136.95% | +171.27% | 2B | |
| +5.95% | +1.44% | -37.17% | +5.80% | 14.63B | |
| +3.15% | -0.76% | -6.62% | +1.36% | 6.29B | |
| +2.38% | +0.43% | -16.16% | +4.68% | 6.28B | |
| +2.36% | -1.22% | -51.12% | -39.40% | 5.68B | |
| -1.27% | -23.72% | -19.75% | -38.34% | 5.01B | |
| +1.16% | -1.75% | -1.14% | -9.60% | 4.58B | |
| +0.22% | +6.79% | -21.58% | -35.68% | 3.16B | |
| -0.16% | +0.66% | +1.38% | -22.99% | 3.15B | |
| +1.44% | +3.86% | -21.34% | +33.07% | 3.03B | |
| Average | +1.69% | -2.38% | -3.65% | +7.02% | 5.38B | |
| Weighted average by Cap. | +2.67% | -3.71% | -17.40% | -1.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.15B 1.06B 961M 1.8B 122B 1.83B 12.67B 5.05B 64.04B 4.82B 4.72B 203B | 2.63B 1.58B 1.42B 1.31B 1.18B 2.21B 151B 2.25B 15.59B 6.22B 78.8B 5.93B 5.81B 250B |
| Net income | 77.85M 46.75M 41.88M 38.63M 34.96M 65.38M 4.45B 66.43M 461M 184M 2.33B 175M 172M 7.38B | 134M 80.19M 71.83M 66.27M 59.97M 112M 7.64B 114M 791M 315M 4B 301M 295M 12.66B |
| Net Debt | 444M 267M 239M 220M 199M 373M 25.4B 379M 2.63B 1.05B 13.3B 1B 980M 42.11B | 541M 325M 291M 269M 243M 455M 30.96B 462M 3.2B 1.28B 16.2B 1.22B 1.19B 51.31B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | €3.320 | +1.22% | 60,549 |
| 28/10/26 | €3.280 | +0.31% | 39,789 |
| 27/10/26 | €3.270 | -0.61% | 56,773 |
| 26/10/26 | €3.290 | -0.90% | 30,115 |
| 23/10/26 | €3.320 | +3.75% | 41,241 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
